It has been shown that the TMEM25 gene is under-expressed in breast and colorectal cancers (Doolan et al, 2009; Hrašovec et al, 2013), and proposed to be used as a tumor biomarker of favorable prognosis (Doolan et al, 2009). The gene discussed is TMEM25; the disease is colorectal cancer.